Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FDQ81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,407
Award facts
- Contract value 100% obligated
- $39,407.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,407 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens on October 16, 2025, with an ultimate completion date of October 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for Cosentyx, a specialty immunosuppressant medication used in rheumatologic conditions, exemplifies the company's role in providing brand-name pharmaceuticals through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB26FDQ81?
SPE2DB26FDQ81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FDQ81 worth?
The government has obligated $39,407 on SPE2DB26FDQ81.
Is contract SPE2DB26FDQ81 an order under another contract?
Yes. SPE2DB26FDQ81 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDQ81 competed?
The extent of competition for SPE2DB26FDQ81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award